ASCL2/MYC tumours displayed the lowest immune infiltration, in contrast to the highly inflamed tumours of the ECM/EMT group showing a maximal tumour purity of 50% (Methods, Supplementary Fig. 11a,b and Supplementary Data 12). This evidence concerns the gene MYC and neoplasm.